Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co IncfiledCriticalAjinomoto Co Inc
Priority to JP5138480ApriorityCriticalpatent/JPS56147774A/en
Publication of JPS56147774ApublicationCriticalpatent/JPS56147774A/en
USE: A carcinostatic agent with low toxicity and good absorbability.
PROCESS: 5-Fluorouracil is reacted with a chloroformic ester of an α, α1-diglyceride expressed by formula II in the presence of a base, e.g. triethylamine, in a solvent, e.g. dimethylformamide, at 0W100°C to give the compound of formula I.